Inventor · disambiguated record
Eti Kovalevski-Ishai
Also filed as: KOVALEVSKI-ISHAI ETI
20 granted patents·7 pending applications·311 citations·filing 2002–2017
96Inventor score
Top patents by PatentIndex Score
27 records- 0196US7973023B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2009·Granted Jul 5, 2011·31 cites·51 claims
- 0296US7504388B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2005·Granted Mar 17, 2009·31 cites·7 claims
- 0395US8158611B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisHARATS DROR·Filed 2011·Granted Apr 17, 2012·18 cites·13 claims
- 0495US7893291B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2009·Granted Feb 22, 2011·24 cites·3 claims
- 0595US7807847B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2007·Granted Oct 5, 2010·17 cites·7 claims
- 0693US8124800B2Process for the preparation of oxidized phospholipidsHALPERIN GIDEON·Filed 2010·Granted Feb 28, 2012·17 cites·10 claims
- 0792US9566288B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2015·Granted Feb 14, 2017·5 cites·35 claims
- 0892US8569529B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Oct 29, 2013·8 cites·20 claims
- 0992US7902176B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2004·Granted Mar 8, 2011·31 cites·107 claims
- 1092US6767913B2Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new formsTEVA PHARMA·Filed 2002·Granted Jul 27, 2004·46 cites·90 claims
- 1191US8802875B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Aug 12, 2014·5 cites·14 claims
- 1290US9006217B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Apr 14, 2015·5 cites·22 claims
- 1390US8563534B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisHARATS DROR·Filed 2012·Granted Oct 22, 2013·8 cites·21 claims
- 1490US7074928B2Polymorphs of clopidogrel hydrogensulfateTEVA PHARMA·Filed 2003·Granted Jul 11, 2006·26 cites·35 claims
- 1589US8759557B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Jun 24, 2014·4 cites·13 claims
- 1689US8501715B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersHARATS DROR·Filed 2011·Granted Aug 6, 2013·8 cites·26 claims
- 1789US6992194B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2004·Granted Jan 31, 2006·16 cites·18 claims
- 1887US9968622B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2017·Granted May 15, 2018·2 cites·18 claims
- 1976US9206206B2Oxidized lipid compounds and uses thereofKOVALEVSKI-ISHAI ETI·Filed 2009·Granted Dec 8, 2015·5 cites·28 claims
- 2074US8999960B2Oxidized thiophospholipid compounds and uses thereofBREITBART EYAL·Filed 2009·Granted Apr 7, 2015·4 cites·35 claims
- 2160US2009209763A1Novel Process For Making Bisphosphonic Acids Using Diluents Other Than Halogenated HydrocarbonsLIDOR-HADAS RAMI·Filed 2009·Application pending·0 cites
- 2260US2010016579A1Crystalline forms of quetiapine hemifumarateTEVA PHARMA·Filed 2009·Application pending·0 cites
- 2357US2012130108A1Process for the preparation of oxidized phospholipidsHALPERIN GIDEON·Filed 2012·Application pending·0 cites
- 2453US2006128960A1Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbonsLIDOR-HADAS RAMI·Filed 2006·Application pending·0 cites
- 2549US2003216376A1Crystalline forms of quetiapine hemifumarateFiled 2003·Application pending·0 cites
- 2648US2013203707A1Oxidized Lipid Compounds and Uses ThereofVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 2742US2003195170A1Novel polymorphs and pseudopolymorphs of risedronate sodiumFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eti Kovalevski-Ishai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →